Pharmacological Ascorbate Enhances Chemotherapies in Pancreatic Ductal Adenocarcinoma
Conclusions
The addition of P-AscH− to standard of care chemotherapy has the potential to be an effective adjuvant for PDAC treatment.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Chemotherapy | Eloxatin | Gastroenterology | Pancreas | Pancreatic Cancer | Study | Vitamin C | Vitamins